Search bioRxiv⌕ Search

Biology subjects

Tynell, J.

Publications and source records attributed to Tynell, J..

3 recordsLinked to original sources

An ONT sequencing framework for hantavirus genome assembly, variant analysis, and defective viral genome characterization from whole-segment amplicons

Orthohantaviruses are zoonotic, tri-segmented negative-sense RNA viruses of rodents and other small mammals that can cause severe human disease. Whole genome sequencing remains difficult because of low viral loads, high sequence diversity, and an inherent instability of the viral L segment. Current tiled amplicon and hybrid-capture approaches do not capture the heterogeneity of virus populations, including defective viral genomes (DVGs), which have never been described for hantaviruses. Here, we present an Oxford Nanopore Technologies sequencing framework based on universal reverse transcription primers targeting the conserved genome termini of orthohantaviruses and a single species-specific primer pair per segment, enabling amplification and sequencing of complete S, M, and L segments. We also developed an accompanying bioinformatic pipeline that performs reference-guided assembly of hantavirus genomes, consensus generation, variant calling, and DVG classification using the newly developed ORCHID classification pipeline. We applied this approach to diverse Puumala virus strains from infected cell cultures and bank voles, to representative Old World and New World orthohantaviruses, and to highly pathogenic New World viruses in vivo. In all cases we were able to accurately reconstruct full hantavirus genomes. Notably, we found that hantavirus populations contain highly abundant DVGs and conserved L segment deletions, whereas the S and M segments remained largely intact. Together, this work provides a low-cost, broadly applicable and easily customisable workflow for hantavirus genomics and reveals DVGs as a previously unrecognized feature of hantavirus populations.

microbiology↗

SARS-CoV-2 variant-specific differences in inhibiting the effects of the PKR-activated integrated stress response

The integrated stress response (ISR) is a eukaryotic cell pathway that triggers translational arrest and the formation of stress granules (SGs) in response to various stress signals, including those caused by viral infections. The SARS-CoV-2 nucleocapsid protein has been shown to disrupt SGs, but SARS-CoV-2 interactions with other components of the pathway remains poorly characterized. Here, we show that SARS-CoV-2 infection triggers the ISR through activation of the eIF2-kinase PKR while inhibiting a variety of downstream effects. In line with previous studies, SG formation was efficiently inhibited and the induced eIF2 phosphorylation only minimally contributed to the translational arrest observed in infected cells. Despite ISR activation and translational arrest, expression of the stress-responsive transcripts ATF4 and CHOP was not induced in SARS-CoV-2 infected cells. Finally, we found variant-specific differences in the activation of the ISR between ancestral SARS-CoV-2 and the Delta and Omicron BA.1 variants in that Delta infection induced weaker PKR activation while Omicron infection induced higher levels of p-eIF2 and greatly increased SG formation compared to the other variants. Our results suggest that different SARS-CoV-2 variants can affect normal cell functions differently, which can have an impact on pathogenesis and treatment strategies.

microbiology↗

Expansion of SARS-CoV-2-specific Antibody-secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019 and has since become a global pandemic. Pathogen-specific antibodies are typically a major predictor of protective immunity, yet B cell and antibody responses during COVID-19 are not fully understood. Here, we analyzed antibody-secreting cell (ASC) and antibody responses in twenty hospitalized COVID-19 patients. The patients exhibited typical symptoms of COVID-19, and presented with reduced lymphocyte numbers and increased T cell and B cell activation. Importantly, we detected an expansion of SARS-CoV-2 nucleocapsid protein-specific ASCs in all twenty COVID-19 patients using a multicolor FluoroSpot assay. Out of the 20 patients, 16 had developed SARS-CoV-2-neutralizing antibodies by the time of inclusion in the study. SARS-CoV-2-specific IgA, IgG and IgM antibody levels positively correlated with SARS-CoV-2-neutralizing antibody titers, suggesting that SARS-CoV-2-specific antibody levels may reflect the titers of neutralizing antibodies in COVID-19 patients during the acute phase of infection. Lastly, we showed that interleukin 6 (IL-6) and C-reactive protein (CRP) concentrations were higher in serum of patients who were hospitalized for longer, supporting the recent observations that IL-6 and CRP could be used to predict COVID-19 severity. Altogether, this study constitutes a detailed description of clinical and immunological parameters in twenty COVID-19 patients, with a focus on B cell and antibody responses, and provides tools to study immune responses to SARS-CoV-2 infection and vaccination.

immunology↗